Eltrombopag

Eltrombopag is a medication that stimulates the bone marrow to produce more platelets, which are blood cells essential for clotting and preventing bleeding. It is used to treat conditions where platelet levels are abnormally low, such as idiopathic thrombocytopenic purpura (ITP) or certain types of bone marrow disorders. By activating the receptor that promotes platelet production, eltrombopag helps reduce bleeding risk. It is taken orally, usually once daily, and requires careful medical supervision to monitor its effects and adjust dosage as needed.